cbdMD, Inc. (YCBD) |
| 1.04 -0.12 (-10.34%) 01-13 16:00 |
| Open: | 1.16 |
| High: | 1.2 |
| Low: | 1.01 |
| Volume: | 1,065,568 |
| Market Cap: | 10(M) |
| PE Ratio: | -0.95 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 2.56 |
| Resistance 1: | 1.81 |
| Pivot price: | 1.28 |
| Support 1: | 0.60 |
| Support 2: | 0.50 |
| 52w High: | 6.536 |
| 52w Low: | 0.47 |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Sat, 10 Jan 2026
cbdMD Inc. (YCBD) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
Sun, 21 Dec 2025
cbdMD Stock Faces New Challenges with Recent Market Developments - timothysykes.com
Fri, 19 Dec 2025
cbdMD raises $2.25 million through preferred stock offering - Investing.com
Fri, 19 Dec 2025
cbdMD Shares Plummet: Buying Opportunity? - timothysykes.com
Fri, 19 Dec 2025
cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance - PR Newswire
Fri, 19 Dec 2025
cbdMD stock rises after third straight year of operational improvement - Investing.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |